Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

30.8%

4 terminated/withdrawn out of 13 trials

Success Rate

42.9%

-43.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
8(88.9%)
Phase 1
1(11.1%)
9Total
N/A(8)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded